Progression from GOLD A/B to GOLD E: a claims analysis of patients with COPD newly initiating inhaled therapy
Despite use of inhaled maintenance treatments for COPD, most patients still progressed to a frequent or severe exacerbator phenotype. New therapies are needed to modify the disease trajectory in COPD.
Authors
- Emily S. Wan (ORCID: https://orcid.org/0000-0002-4126-2467)
- A. R. Dixon (ORCID: https://orcid.org/0000-0002-8582-4062)
- Vickram Tejwani (ORCID: https://orcid.org/0000-0003-2100-6148)
- Sanjay Sethi (ORCID: https://orcid.org/0009-0001-5367-3730)
- Trishul Siddharthan (ORCID: https://orcid.org/0000-0001-9914-1839)
- Claudia Lamprey
- Kavita Aggarwal (ORCID: https://orcid.org/0000-0001-9976-8703)
- Yi Pan
Institutions
- Brigham and Women's Hospital (US)
- Cleveland Clinic (US)
- University of Miami (US)
- VA Boston Healthcare System (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Jacobs (United States) (US)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1186/s12890-025-03898-1
- Citations
- 3
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56